Want to see HK:1931 full AI Analyst Report?
1931 Stock Chart & Stats
HK$3.85
HK$0.05(2.67%)
At close: 4:00 PM EST
HK$3.85
HK$0.05(2.67%)
Day’s Range― - ―
52-Week RangeHK$0.56 - HK$11.96
Previous CloseN/A
Volume18.00K
Average Volume (3M)1.48M
Market Cap
HK$924.25M
Enterprise ValueHK$5.81K
Total Cash (Recent Filing)HK$551.05M
Total Debt (Recent Filing)HK$1.93B
Price to Earnings (P/E)23.3
Beta0.54
Next Earnings
Mar 12, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.81%
Share Statistics
EPS (TTM)0.02
Shares Outstanding1,621,488,000
10 Day Avg. Volume1,443,300
30 Day Avg. Volume1,483,483
Financial Highlights & Ratios
PEG Ratio-1.25
Price to Book (P/B)1.29
Price to Sales (P/S)1.35
P/FCF Ratio-3.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Historic Cash GenerationThe company delivered positive operating and free cash flow through 2021–2024 before the 2025 swing. That multi-year history shows the business model can generate cash under normal conditions, implying the potential to restore cash conversion if working-capital pressures and one-off outflows are addressed.
Sizable Equity BaseDespite 2025 deterioration, the balance sheet still reports a sizable equity base reflecting accumulated book value from prior profitable years. A substantive equity cushion supports solvency and gives management time to restructure operations or access capital without immediate insolvency risk.
Operational Scale And Lower VolatilityA low beta and a workforce of ~910 suggest an established distribution operation with operational scale that can absorb demand variability. Scale and lower stock volatility often reflect diversified customer relationships and recurring distribution contracts that underpin steadier revenue over medium term.
Bears Say
Revenue And Margin CollapseA sharp drop in revenue and dramatic margin compression in 2025 indicate weakened pricing power or deteriorating operating leverage. Sustained lower margins reduce internal funding for capex and dividends and imply the core distribution economics have been impaired, raising structural profitability risk.
Severe Cash-Flow DeteriorationDeep negative operating and free cash flow materially increase funding and liquidity risk. Persistent cash outflows force reliance on external financing, constrain reinvestment, and limit flexibility to recover operations, making any turnaround dependent on rapid restoration of cash conversion or new capital.
Rising LeverageLeverage tripling year-over-year significantly tightens financial flexibility. Higher debt increases fixed obligations and refinancing risk, particularly when earnings and cash flow have weakened, which can force asset sales, equity dilution, or cost-cutting that harm long-term competitive positioning.
IVD Medical Holding Limited News
1931 FAQ
What was IVD Medical Holding Limited’s price range in the past 12 months?
IVD Medical Holding Limited lowest stock price was HK$0.56 and its highest was HK$11.96 in the past 12 months.
What is IVD Medical Holding Limited’s market cap?
IVD Medical Holding Limited’s market cap is HK$924.25M.
When is IVD Medical Holding Limited’s upcoming earnings report date?
IVD Medical Holding Limited’s upcoming earnings report date is Mar 12, 2027 which is in 209 days.
How were IVD Medical Holding Limited’s earnings last quarter?
Currently, no data Available
Is IVD Medical Holding Limited overvalued?
According to Wall Street analysts IVD Medical Holding Limited’s price is currently Overvalued.
Does IVD Medical Holding Limited pay dividends?
IVD Medical Holding Limited pays a Notavailable dividend of HK$0.062 which represents an annual dividend yield of 3.81%. See more information on IVD Medical Holding Limited dividends here
What is IVD Medical Holding Limited’s EPS estimate?
IVD Medical Holding Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IVD Medical Holding Limited have?
IVD Medical Holding Limited has 1,621,488,000 shares outstanding.
What happened to IVD Medical Holding Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of IVD Medical Holding Limited?
Currently, no hedge funds are holding shares in HK:1931
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
IVD Medical Holding Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
320.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
12.45%
Trailing 12-Months
Company Description
IVD Medical Holding Limited
null
Technical Analysis
China Health Group
―
Shanghai Pharmaceuticals Holding Co
―
Sinopharm Group Co
―
Medlive Technology Co., Ltd.
―
Charmacy Pharmaceutical Co., Ltd. Class H
―